https://lyoresearch.com/ 2026-09-03T00:00:00.000Z weekly 1 https://lyoresearch.com/compounds 2026-09-03T00:00:00.000Z weekly 0.9 https://lyoresearch.com/methodology 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/learn 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/learn/what-a-peptide-is 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/learn/animal-studies-vs-human-trials 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/learn/how-lyo-grades-evidence 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/learn/what-a-purity-test-proves 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/learn/regulation-by-region 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/learn/spotting-a-bad-claim 2026-09-03T00:00:00.000Z monthly 0.7 https://lyoresearch.com/regulation 2026-09-03T00:00:00.000Z weekly 0.9 https://lyoresearch.com/regulation/us 2026-09-02T00:00:00.000Z weekly 0.85 https://lyoresearch.com/regulation/eu 2026-09-02T00:00:00.000Z weekly 0.85 https://lyoresearch.com/regulation/uk 2026-09-02T00:00:00.000Z weekly 0.85 https://lyoresearch.com/regulation/australia 2026-09-02T00:00:00.000Z weekly 0.85 https://lyoresearch.com/regulation/canada 2026-09-02T00:00:00.000Z weekly 0.85 https://lyoresearch.com/regulation/sport 2026-09-02T00:00:00.000Z weekly 0.85 https://lyoresearch.com/about 2026-09-03T00:00:00.000Z monthly 0.5 https://lyoresearch.com/contact 2026-09-03T00:00:00.000Z yearly 0.3 https://lyoresearch.com/compare/tirzepatide-vs-semaglutide 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compare/retatrutide-vs-tirzepatide 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compare/semaglutide-vs-liraglutide 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compare/bpc-157-vs-tb-500 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compare/cjc-1295-vs-sermorelin 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/bpc-157 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/semaglutide 2026-09-01T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/retatrutide 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/tirzepatide 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/tesamorelin 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/ipamorelin 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/ghk-cu 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/epitalon 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/tb-500 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/cagrilintide 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/semax 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/selank 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/pt-141 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/sermorelin 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/cjc-1295 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/aod-9604 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/mots-c 2026-09-02T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/liraglutide 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/survodutide 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/mazdutide 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/kisspeptin 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/thymosin-alpha-1 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/ll-37 2026-09-03T00:00:00.000Z monthly 0.8 https://lyoresearch.com/compounds/bpc-157/tendon-and-ligament-healing 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/bpc-157/gut-mucosal-healing 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/bpc-157/pain-reduction 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/bpc-157/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semaglutide/body-weight 2026-09-01T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semaglutide/blood-glucose-hba1c 2026-09-01T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semaglutide/major-cardiovascular-events 2026-09-01T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semaglutide/gi-side-effects 2026-09-01T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semaglutide/lean-mass-loss 2026-09-01T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/retatrutide/body-weight 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/retatrutide/knee-osteoarthritis-pain 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/retatrutide/gi-side-effects 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/retatrutide/dysesthesia-skin-sensation-changes 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tirzepatide/body-weight 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tirzepatide/blood-glucose-hba1c 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tirzepatide/obstructive-sleep-apnoea 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tirzepatide/cardiovascular-events 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tirzepatide/gi-side-effects 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tesamorelin/visceral-fat-hiv-lipodystrophy 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tesamorelin/liver-fat-hiv-with-nafld 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tesamorelin/cognition-in-older-adults 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tesamorelin/fat-loss-in-healthy-adults 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tesamorelin/igf-1-elevation-and-glucose-effects 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ipamorelin/growth-hormone-release 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ipamorelin/post-operative-ileus-gut-recovery 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ipamorelin/body-composition 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ipamorelin/sleep-or-recovery 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ipamorelin/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ghk-cu/skin-appearance-topical 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ghk-cu/wound-healing-topical 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ghk-cu/hair-growth 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ghk-cu/any-outcome-injected 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/epitalon/lifespan-mortality 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/epitalon/telomerase-activation 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/epitalon/melatonin-sleep 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/epitalon/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tb-500/tendon-muscle-and-ligament-healing-injected 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tb-500/dry-eye-disease-topical-rgn-259 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tb-500/cardiac-repair 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/tb-500/safety-in-humans-injected 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cagrilintide/body-weight-with-semaglutide-cagrisema 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cagrilintide/body-weight-alone 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cagrilintide/gi-side-effects 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semax/cognitive-performance 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semax/stroke-recovery 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semax/anxiety-stress 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/semax/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/selank/anxiety 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/selank/cognitive-effects 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/selank/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/pt-141/sexual-desire-premenopausal-women-hsdd 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/pt-141/sexual-distress-same-population 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/pt-141/erectile-function-use-in-men 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/pt-141/nausea 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/pt-141/flushing-and-headache 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/sermorelin/growth-hormone-igf-1-elevation 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/sermorelin/body-composition-in-adults 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/sermorelin/sleep-quality 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/sermorelin/safety-in-adults 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cjc-1295/growth-hormone-igf-1-elevation 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cjc-1295/body-composition 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cjc-1295/any-clinical-outcome 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/cjc-1295/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/aod-9604/fat-mass-reduction 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/aod-9604/body-weight 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/aod-9604/osteoarthritis-cartilage 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/aod-9604/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mots-c/insulin-sensitivity-metabolic-health 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mots-c/exercise-capacity 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mots-c/longevity 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mots-c/safety-in-humans 2026-09-02T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/body-weight-adults 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/major-cardiovascular-events 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/blood-glucose-hba1c 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/body-weight-adolescents-12-17 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/body-weight-children-6-11 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/gi-side-effects 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/liraglutide/gallbladder-events 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/survodutide/body-weight 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/survodutide/liver-disease-mash-resolution 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/survodutide/liver-fat-and-visceral-fat 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/survodutide/gi-side-effects 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/survodutide/heart-rate-increase 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mazdutide/body-weight 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mazdutide/liver-fat 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mazdutide/blood-glucose-hba1c 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/mazdutide/gi-side-effects 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/kisspeptin/lh-and-testosterone-release 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/kisspeptin/ivf-egg-maturation-trigger 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/kisspeptin/sexual-desire-women-with-hsdd 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/kisspeptin/sexual-desire-and-arousal-men-with-hsdd 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/kisspeptin/safety 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/thymosin-alpha-1/sepsis-mortality 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/thymosin-alpha-1/chronic-hepatitis-b-viral-response 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/thymosin-alpha-1/vaccine-response-in-the-elderly-and-dialysis-patients 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/thymosin-alpha-1/covid-19-outcomes 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/thymosin-alpha-1/safety 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ll-37/venous-leg-ulcer-healing-topical 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ll-37/antimicrobial-action-in-people 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ll-37/systemic-immune-support-or-anti-inflammatory-use 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/compounds/ll-37/safety-topical 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/glossary 2026-09-03T00:00:00.000Z monthly 0.6 https://lyoresearch.com/glossary/peptide 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/amino-acid 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/lyophilized 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/rct 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/placebo 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/open-label 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/case-series 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/primary-endpoint 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/effect-size 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/confidence-interval 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/systematic-review 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/meta-analysis 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/phase-1-2-3 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/topline-results 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/peer-review 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/grade 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/glp-1-receptor-agonist 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/incretin 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/gip 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/glucagon 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/amylin 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/growth-hormone-secretagogue 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/ghrh 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/ghrelin 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/melanocortin 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/half-life 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/bioavailability 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/subcutaneous 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/hba1c 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/mace 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/marketing-authorisation 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/off-label 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/compounding 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/research-use-only 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/coa 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/purity 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/schedule-4 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/wada-prohibited-list 2026-09-03T00:00:00.000Z yearly 0.4 https://lyoresearch.com/glossary/citation 2026-09-03T00:00:00.000Z yearly 0.4